Hutchmed Drc Stock Analysis

HCM Stock  USD 15.42  0.39  2.47%   
HUTCHMED DRC is overvalued with Real Value of 12.68 and Target Price of 25.67. The main objective of HUTCHMED DRC stock analysis is to determine its intrinsic value, which is an estimate of what HUTCHMED DRC is worth, separate from its market price. There are two main types of HUTCHMED DRC's stock analysis: fundamental analysis and technical analysis.
The HUTCHMED DRC stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. HUTCHMED DRC is usually not traded on National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. HUTCHMED Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.

HUTCHMED Stock Analysis Notes

The book value of the company was currently reported as 0.89. The company has Price/Earnings (P/E) ratio of 335.94. HUTCHMED DRC had not issued any dividends in recent years. The entity had 1:1 split on the 30th of May 2019. HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchmed China operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2110 people. To learn more about HUTCHMED DRC call Weiguo BSc at 852 2121 8200 or check out https://www.hutch-med.com.

HUTCHMED DRC Quarterly Total Revenue

162.26 Million

HUTCHMED DRC Investment Alerts

HUTCHMED DRC had very high historical volatility over the last 90 days
Latest headline from gurufocus.com: Harraden Circle Investments, LLC Expands Stake in Aldel Financial II Inc

HUTCHMED DRC Upcoming and Recent Events

27th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

HUTCHMED Largest EPS Surprises

Earnings surprises can significantly impact HUTCHMED DRC's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2018-07-27
2018-06-30-0.16-0.140.0212 
2018-05-30
2018-03-31-0.16-0.140.0212 
2020-11-13
2020-09-30-0.2052-0.18450.020710 
View All Earnings Estimates

HUTCHMED DRC Thematic Classifications

In addition to having HUTCHMED DRC stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Cancer Fighters Idea
Cancer Fighters
Public companies from health care and pharmaceutical sectors that are focused on fighting cancer

HUTCHMED Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Millennium Management Llc2025-03-31
110.6 K
Goldman Sachs Group Inc2025-03-31
93.9 K
Blackrock Inc2025-03-31
73.3 K
Hennion & Walsh Asset Management Inc2025-03-31
48.8 K
Two Sigma Investments Llc2025-03-31
47.3 K
Dekabank Deutsche Girozentrale2025-03-31
41.4 K
Connor Clark & Lunn Inv Mgmt Ltd2025-03-31
29.4 K
Abc Arbitrage Sa2025-03-31
25.4 K
Crossmark Global Holdings, Inc.2025-03-31
24.4 K
Schroder Investment Management Group2025-03-31
2.8 M
Allianz Asset Management Ag2025-03-31
M
Note, although HUTCHMED DRC's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

HUTCHMED Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 2.7 B.

HUTCHMED Profitablity

The company has Net Profit Margin of 0.06 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of (0.05) %, which entails that for every $100 of revenue, it lost $0.05.

Management Efficiency

HUTCHMED DRC has Return on Asset of (0.0214) % which means that on every $100 spent on assets, it lost $0.0214. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0504 %, implying that it generated $0.0504 on every 100 dollars invested. HUTCHMED DRC's management efficiency ratios could be used to measure how well HUTCHMED DRC manages its routine affairs as well as how well it operates its assets and liabilities. At this time, HUTCHMED DRC's Total Assets are very stable compared to the past year. As of the 8th of July 2025, Non Currrent Assets Other is likely to grow to about 745.5 M, while Intangible Assets are likely to drop about 18 K.
HUTCHMED DRC showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Operating Margin
(0.05)
Profit Margin
0.0599
Beta
0.605
Return On Assets
(0.02)
Return On Equity
0.0504

Technical Drivers

As of the 8th of July, HUTCHMED DRC retains the market risk adjusted performance of 0.0233, and Risk Adjusted Performance of 0.0167. HUTCHMED DRC technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out HUTCHMED DRC information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if HUTCHMED DRC is priced adequately, providing market reflects its last-minute price of 15.42 per share. Given that HUTCHMED DRC has jensen alpha of (0.1), we strongly advise you to confirm HUTCHMED DRC's regular market performance to make sure the company can sustain itself next year.

HUTCHMED DRC Price Movement Analysis

Study
Time Period
Deviations up
Deviations down
MA Type
Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. HUTCHMED DRC middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for HUTCHMED DRC. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

HUTCHMED DRC Outstanding Bonds

HUTCHMED DRC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. HUTCHMED DRC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most HUTCHMED bonds can be classified according to their maturity, which is the date when HUTCHMED DRC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

HUTCHMED DRC Predictive Daily Indicators

HUTCHMED DRC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of HUTCHMED DRC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

HUTCHMED DRC Forecast Models

HUTCHMED DRC's time-series forecasting models are one of many HUTCHMED DRC's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary HUTCHMED DRC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About HUTCHMED Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how HUTCHMED DRC prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling HUTCHMED shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as HUTCHMED DRC. By using and applying HUTCHMED Stock analysis, traders can create a robust methodology for identifying HUTCHMED entry and exit points for their positions.
HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchmed China operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2110 people.

Current HUTCHMED Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. HUTCHMED analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. HUTCHMED analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
25.67Strong Buy14Odds
HUTCHMED DRC current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most HUTCHMED analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand HUTCHMED stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of HUTCHMED DRC, talking to its executives and customers, or listening to HUTCHMED conference calls.
HUTCHMED Analyst Advice Details

HUTCHMED Stock Analysis Indicators

HUTCHMED DRC stock analysis indicators help investors evaluate how HUTCHMED DRC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading HUTCHMED DRC shares will generate the highest return on investment. By understating and applying HUTCHMED DRC stock analysis, traders can identify HUTCHMED DRC position entry and exit signals to maximize returns.
Begin Period Cash Flow283.6 M
Long Term Debt59.4 M
Common Stock Shares Outstanding174.6 M
Total Stockholder Equity759.9 M
Tax Provision7.2 M
Quarterly Earnings Growth Y O Y-0.842
Property Plant And Equipment Net97 M
Cash And Short Term Investments836.1 M
Cash154 M
Accounts Payable42.5 M
Net Debt-64.1 M
50 Day M A14.8422
Total Current Liabilities376.6 M
Other Operating Expenses673.9 M
Non Current Assets Total207.6 M
Forward Price Earnings7.9872
Non Currrent Assets Other710 M
Stock Based Compensation21.6 M
When determining whether HUTCHMED DRC is a strong investment it is important to analyze HUTCHMED DRC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact HUTCHMED DRC's future performance. For an informed investment choice regarding HUTCHMED Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.84)
Earnings Share
0.2
Revenue Per Share
3.685
Quarterly Revenue Growth
0.064
Return On Assets
(0.02)
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.